XyloCor Therapeutics
Todd Rosengart, MD, is Professor and DeBakey-Bard Chairman, Department of Surgery, Baylor Medical College; Professor of Heart and Vascular Disease at the Texas Heart Institute. He has been a leading researcher in cardiac angiogenesis and regeneration for more than 30 years and together with Ron Crystal, M.D. was the first to administer the adenovirus vector for cardiac gene transfer in the U.S. Dr. Rosengart is also co‑founder of Vitals.com
This person is not in the org chart
This person is not in any offices
XyloCor Therapeutics
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.